Sign in
MTRY Stock Price, Chart, Stats & News
Monterey Bio Acquisition Corporation
Save
48.30M
Market cap
–
Current P/E
–
Forward P/E
MTRY chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -10.01% |
ROA | -5.95% |
ROE | -1.86% |
D/E | – |
Interest coverage ratio | – |
MTRY valuation
P/E | – |
P/S | – |
P/B | 1.62x |
P/CF | -31.90x |
P/FCF | -48.11x |
P/OCF | -31.90x |
PEG | -0.25x |
EV multiple | -23.76x |
About
Monterey Bio Acquisition Corporation currently lacks substantial operational activities. Its primary goal is to achieve a business combination—including but not limited to mergers, capital stock exchanges, asset acquisitions, or reorganizations—with companies in the biotechnology industry. The firm, established in 2020, was formerly known as Chardan FinTech Acquisition Corp. and rebranded to Monterey Bio Acquisition Corporation in April 2021.
Similar securities
Based on sector and market capitalization
Report issue